These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 31127647)
1. Circulating ctDNA methylation quantification of two DNA methyl transferases in papillary thyroid carcinoma. Khatami F; Teimoori-Toolabi L; Heshmat R; Nasiri S; Saffar H; Mohammadamoli M; Aghdam MH; Larijani B; Tavangar SM J Cell Biochem; 2019 Oct; 120(10):17422-17437. PubMed ID: 31127647 [TBL] [Abstract][Full Text] [Related]
2. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer. Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600 [TBL] [Abstract][Full Text] [Related]
3. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer. Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405 [TBL] [Abstract][Full Text] [Related]
5. Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma. Khatami F; Larijani B; Heshmat R; Nasiri S; Saffar H; Shafiee G; Mossafa A; Tavangar SM Iran J Pathol; 2019; 14(4):290-298. PubMed ID: 31754358 [TBL] [Abstract][Full Text] [Related]
6. Status of O⁶ -methylguanine-DNA methyltransferase [MGMT] gene promoter methylation among patients with glioblastomas from India. Nehru GA; Pai R; Samuel P; Chacko AG; Chacko G Neurol India; 2012; 60(5):481-6. PubMed ID: 23135024 [TBL] [Abstract][Full Text] [Related]
7. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer. Spitzwieser M; Holzweber E; Pfeiler G; Hacker S; Cichna-Markl M Breast Cancer Res; 2015 Sep; 17(1):125. PubMed ID: 26370119 [TBL] [Abstract][Full Text] [Related]
8. Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas. Gömöri E; Pál J; Kovács B; Dóczi T Diagn Pathol; 2012 Jan; 7():8. PubMed ID: 22264301 [TBL] [Abstract][Full Text] [Related]
9. O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation is a rare event in soft tissue sarcoma. Jakob J; Hille M; Sauer C; Ströbel P; Wenz F; Hohenberger P Radiat Oncol; 2012 Oct; 7():180. PubMed ID: 23110891 [TBL] [Abstract][Full Text] [Related]
10. Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics. Jiang S; Rui Q; Wang Y; Heo HY; Zou T; Yu H; Zhang Y; Wang X; Du Y; Wen X; Chen F; Wang J; Eberhart CG; Zhou J; Wen Z Eur Radiol; 2018 May; 28(5):2115-2123. PubMed ID: 29234914 [TBL] [Abstract][Full Text] [Related]
11. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast. Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821 [TBL] [Abstract][Full Text] [Related]
12. MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response. Switzeny OJ; Christmann M; Renovanz M; Giese A; Sommer C; Kaina B Clin Epigenetics; 2016; 8():49. PubMed ID: 27158275 [TBL] [Abstract][Full Text] [Related]
13. Promoter methylation of O(6)-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53. Lai JC; Cheng YW; Goan YG; Chang JT; Wu TC; Chen CY; Lee H DNA Repair (Amst); 2008 Aug; 7(8):1352-63. PubMed ID: 18555750 [TBL] [Abstract][Full Text] [Related]
14. Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer. Barault L; Amatu A; Bleeker FE; Moutinho C; Falcomatà C; Fiano V; Cassingena A; Siravegna G; Milione M; Cassoni P; De Braud F; Rudà R; Soffietti R; Venesio T; Bardelli A; Wesseling P; de Witt Hamer P; Pietrantonio F; Siena S; Esteller M; Sartore-Bianchi A; Di Nicolantonio F Ann Oncol; 2015 Sep; 26(9):1994-1999. PubMed ID: 26113646 [TBL] [Abstract][Full Text] [Related]
15. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients. Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586 [TBL] [Abstract][Full Text] [Related]
16. Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis. Han Y; Yan LF; Wang XB; Sun YZ; Zhang X; Liu ZC; Nan HY; Hu YC; Yang Y; Zhang J; Yu Y; Sun Q; Tian Q; Hu B; Xiao G; Wang W; Cui GB BMC Cancer; 2018 Feb; 18(1):215. PubMed ID: 29467012 [TBL] [Abstract][Full Text] [Related]
17. Pyrosequencing Analysis of Panagopoulos I; Gorunova L; Leske H; Niehusmann P; Johannessen LE; Staurseth J; Øino N; Meling TR; Heim S; Micci F; Brandal P Cancer Genomics Proteomics; 2018; 15(5):379-385. PubMed ID: 30194078 [TBL] [Abstract][Full Text] [Related]
18. Promoter methylation of MGMT gene in serum of patients with esophageal squamous cell carcinoma in North East India. Das M; Sharma SK; Sekhon GS; Saikia BJ; Mahanta J; Phukan RK Asian Pac J Cancer Prev; 2014; 15(22):9955-60. PubMed ID: 25520135 [TBL] [Abstract][Full Text] [Related]
19. Defining optimal cutoff value of MGMT promoter methylation by ROC analysis for clinical setting in glioblastoma patients. Yuan G; Niu L; Zhang Y; Wang X; Ma K; Yin H; Dai J; Zhou W; Pan Y J Neurooncol; 2017 May; 133(1):193-201. PubMed ID: 28516344 [TBL] [Abstract][Full Text] [Related]
20. Detection of MGMT promoter methylation in glioblastoma using pyrosequencing. Xie H; Tubbs R; Yang B Int J Clin Exp Pathol; 2015; 8(1):636-42. PubMed ID: 25755756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]